Abu Dhabi, United Arab Emirates
Abu Dhabi, United Arab Emirates

Time filter

Source Type

News Article | May 15, 2017
Site: marketersmedia.com

— The “Public Safety LTE & Mobile Broadband Market: 2016 – 2030 – Opportunities, Challenges, Strategies & Forecasts” report presents an in-depth assessment of the global public safety LTE market, besides touching upon the wider LMR and mobile broadband industries. In addition to covering the business case, challenges, technology, spectrum allocation, industry roadmap, value chain, deployment case studies, vendor products, strategies, standardization initiatives and applications ecosystem for public safety LTE, the report also presents comprehensive forecasts for mobile broadband, LMR and public safety LTE subscriptions from 2016 till 2030. Browse 11 Chapters, 504 companies and 153 table and figures spread across 529 pages report @ http://www.reportsnreports.com/contacts/discount.aspx?name=560702. Also covered are public safety LTE service revenues, over both private and commercial networks. In addition, the report presents revenue forecasts for public safety LTE infrastructure, devices, integration services and management solutions. Latest research estimates that annual investments on public safety LTE infrastructure will reach $600 Million by the end of 2016. The market, which includes base stations (eNBs), mobile core and transport networking gear, is further expected to grow at a CAGR of 33% over the next four years. By 2020, these infrastructure investments will be complemented by over 4.4 Million LTE device shipments, including smartphones, rugged handheld terminals and vehicular routers. Due to the bandwidth limitations of their traditional voice-centric LMR (Land Mobile Radio) networks, public safety agencies are keen to leverage commercial cellular network technology to support their growing broadband application needs. Considering its thriving ecosystem, spectrum flexibility and performance metrics, LTE has emerged as the leading candidate for public safety mobile broadband networks. In addition, with the recent approval of the MCPTT (Mission Critical Push to Talk) voice standard as part of 3GPP Release 13, LTE has also become an attractive substitute for providing LMR-like voice services. The following companies and organizations have been reviewed, discussed or mentioned in the report: 3GPP (Third Generation Partnership Project), Aaeon, Abu Dhabi Police, Accelleran, AceAxis, ACMA (Australian Communications and Media Authority), Aculab, Adax, ADCOM911 (Adams County Communication Center), ADRF (Advanced RF Technologies), Advantech, Advantech Wireless, Aeroflex, Affarii Technologies, Affirmed Networks, Agile Networks, Airbus Defence and Space, Airbus Group, Air-Lynx, Airspan Networks, Airvana, Airwave Solutions, Ajman Police, Alcatel-Lucent, Altiostar Networks, Amdocs, Anite, Anritsu Corporation, APCO International (Association of Public-Safety Communications Officials), Apple, ARASKOM, Arcadyan, Argela, Aricent, ARItel, Arqiva, Artemis Networks, Aselsan, ASOCS, ASTRI (Hong Kong Applied Science and Technology Research Institute), ASTRID, ASTRO Solutions, Asus (ASUSTeK Computer), AT&T, Athena Wireless Communications, Athonet, ATIS (Alliance for Telecommunications Industry Solutions), Atlas Telecom, Avanti Communications Group Topics Covered: • Business case for public safety LTE and mobile broadband services, including key benefits and challenges • Technology, economics, trends, commercial commitments and deployment case studies • List of public safety LTE engagements worldwide • Public safety LTE infrastructure, devices and applications • Industry roadmap, value chain and standardization initiatives • Spectrum allocation, deployment models and funding strategies • Profiles and strategies of over 260 ecosystem players including public safety system integrators and LTE infrastructure/device OEMs • TCO analysis of private and commercial public safety LTE deployments • Military and tactical LTE deployments • Public safety LTE base station (eNB) form factor analysis • Exclusive interview transcripts from 5 key ecosystem players: Ericsson, Airbus Defence and Space, Sepura, Aricent and Parallel Wireless • Strategic recommendations for vendors, system integrators, public safety agencies and mobile operators • Public Safety LTE & Mobile Broadband Market analysis and forecasts from 2016 till 2030 ReportsnReports.com is single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. For more information, please visit http://www.reportsnreports.com/reports/560702-the-public-safety-lte-mobile-broadband-market-2016-2030-opportunities-challenges-strategies-forecasts.html?utm_source=MMgiti


Sibley A.,Center for Disease Analysis | Han K.H.,Yonsei University | Abourached A.,Ministry of Public Health | Lesmana L.A.,University of Indonesia | And 127 more authors.
Journal of Viral Hepatitis | Year: 2015

The total number, morbidity and mortality attributed to viraemic hepatitis C virus (HCV) infections change over time making it difficult to compare reported estimates from different years. Models were developed for 15 countries to quantify and characterize the viraemic population and forecast the changes in the infected population and the corresponding disease burden from 2014 to 2030. With the exception of Iceland, Iran, Latvia and Pakistan, the total number of viraemic HCV infections is expected to decline from 2014 to 2030, but the associated morbidity and mortality are expected to increase in all countries except for Japan and South Korea. In the latter two countries, mortality due to an ageing population will drive down prevalence, morbidity and mortality. On the other hand, both countries have already experienced a rapid increase in HCV-related mortality and morbidity. HCV-related morbidity and mortality are projected to increase between 2014 and 2030 in all other countries as result of an ageing HCV-infected population. Thus, although the total number of HCV countries is expected to decline in most countries studied, the associated disease burden is expected to increase. The current treatment paradigm is inadequate if large reductions in HCV-related morbidity and mortality are to be achieved. © 2015 John Wiley & Sons Ltd.


Liakina V.,Vilnius University | Liakina V.,Vilnius Gediminas Technical University | Hamid S.,Aga Khan University | Tanaka J.,Hiroshima University | And 139 more authors.
Journal of Viral Hepatitis | Year: 2015

Detailed, country-specific epidemiological data are needed to characterize the burden of chronic hepatitis C virus (HCV) infection around the world. With new treatment options available, policy makers and public health officials must reconsider national strategies for infection control. In this study of 15 countries, published and unpublished data on HCV prevalence, viraemia, genotype, age and gender distribution, liver transplants and diagnosis and treatment rates were gathered from the literature and validated by expert consensus in each country. Viraemic prevalence in this study ranged from 0.2% in Iran and Lebanon to 4.2% in Pakistan. The largest viraemic populations were in Pakistan (7 001 000 cases) and Indonesia (3 187 000 cases). Injection drug use (IDU) and a historically unsafe blood supply were major risk factors in most countries. Diagnosis, treatment and liver transplant rates varied widely between countries. However, comparison across countries was difficult as the number of cases changes over time. Access to reliable data on measures such as these is critical for the development of future strategies to manage the disease burden. © 2015 John Wiley & Sons Ltd.


PubMed | Dow Medical College, University of Ulsan, Daman National Health Insurance Company, Ministry of Health and 60 more.
Type: | Journal: Journal of viral hepatitis | Year: 2015

Detailed, country-specific epidemiological data are needed to characterize the burden of chronic hepatitis C virus (HCV) infection around the world. With new treatment options available, policy makers and public health officials must reconsider national strategies for infection control. In this study of 15 countries, published and unpublished data on HCV prevalence, viraemia, genotype, age and gender distribution, liver transplants and diagnosis and treatment rates were gathered from the literature and validated by expert consensus in each country. Viraemic prevalence in this study ranged from 0.2% in Iran and Lebanon to 4.2% in Pakistan. The largest viraemic populations were in Pakistan (7 001 000 cases) and Indonesia (3 187 000 cases). Injection drug use (IDU) and a historically unsafe blood supply were major risk factors in most countries. Diagnosis, treatment and liver transplant rates varied widely between countries. However, comparison across countries was difficult as the number of cases changes over time. Access to reliable data on measures such as these is critical for the development of future strategies to manage the disease burden.


PubMed | Dow Medical College, University of Ulsan, Victor Babes University of Medicine and Pharmacy Timisoara, Ministry of Health and 61 more.
Type: | Journal: Journal of viral hepatitis | Year: 2015

The total number, morbidity and mortality attributed to viraemic hepatitis C virus (HCV) infections change over time making it difficult to compare reported estimates from different years. Models were developed for 15 countries to quantify and characterize the viraemic population and forecast the changes in the infected population and the corresponding disease burden from 2014 to 2030. With the exception of Iceland, Iran, Latvia and Pakistan, the total number of viraemic HCV infections is expected to decline from 2014 to 2030, but the associated morbidity and mortality are expected to increase in all countries except for Japan and South Korea. In the latter two countries, mortality due to an ageing population will drive down prevalence, morbidity and mortality. On the other hand, both countries have already experienced a rapid increase in HCV-related mortality and morbidity. HCV-related morbidity and mortality are projected to increase between 2014 and 2030 in all other countries as result of an ageing HCV-infected population. Thus, although the total number of HCV countries is expected to decline in most countries studied, the associated disease burden is expected to increase. The current treatment paradigm is inadequate if large reductions in HCV-related morbidity and mortality are to be achieved.


PubMed | Dow Medical College, University of Ulsan, Victor Babes University of Medicine and Pharmacy Timisoara, Ministry of Health and 60 more.
Type: | Journal: Journal of viral hepatitis | Year: 2015

The hepatitis C virus (HCV) epidemic was forecasted through 2030 for 15 countries in Europe, the Middle East and Asia, and the relative impact of two scenarios was considered: increased treatment efficacy while holding the annual number of treated patients constant and increased treatment efficacy and an increased annual number of treated patients. Increasing levels of diagnosis and treatment, in combination with improved treatment efficacy, were critical for achieving substantial reductions in disease burden. A 90% reduction in total HCV infections within 15 years is feasible in most countries studied, but it required a coordinated effort to introduce harm reduction programmes to reduce new infections, screening to identify those already infected and treatment with high cure rate therapies. This suggests that increased capacity for screening and treatment will be critical in many countries. Birth cohort screening is a helpful tool for maximizing resources. Among European countries, the majority of patients were born between 1940 and 1985. A wider range of birth cohorts was seen in the Middle East and Asia (between 1925 and 1995).

Loading Abu Dhabi Police collaborators
Loading Abu Dhabi Police collaborators